ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head studyFirst head-to-head, double-blind, ...
Combining cannabis with an opioid did not improve acute pain for people with knee arthritis, according to results of a study ...
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) ...
The RELIEVE trial assesses remibrutinib's efficacy and safety in generalized myasthenia gravis, involving 180 participants in a 6-month double-blind study. Remibrutinib has shown a positive safety ...
Prescribing Patterns and Real-World Clinical Usage of Adjuvant Abemaciclib for Early-Stage, High-Risk, Estrogen Receptor–Positive Breast Cancer Participants were randomly assigned 1:1:1 to receive ...
Hand-foot syndrome (HFS) is a dose-limiting side effect of capecitabine. Celecoxib prevents HFS by inhibiting cyclooxygenase-2 (COX-2) that is upregulated because of the underlying associated ...
A new clinical study shows a plant-based hair serum may boost thickness and density in just 8 weeks. Researchers report ...
Objectives To investigate if daily treatment with glyceryl trinitrate (GTN) ointment, over 24 weeks combined with a 12-week eccentric exercise programme is more effective for chronic mid-portion ...